Home
RENEU
RENEU News

Latest CARTESIAN GROWTH CORPORATION II UNIT COM 1 CL A & 1/3 WT EXP(12/07/2028) (RENEU) News on July 26, 2024

Cartesian Growth Corporation II (NASDAQ:RENE) is largely controlled by institutional shareholders who own 70% of the company

Simply Wall St.

6 months ago

Cartesian Growth Corporation II (NASDAQ:RENE) is largely controlled by institutional shareholders who own 70% of the company

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/02/2024

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering

GlobeNewswire

6 months ago

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering

Protara Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

6 months ago

Protara Therapeutics to Participate in Upcoming Investor Conferences

Corbus Pharmaceuticals Announces Proposed Public Offering

GlobeNewswire

6 months ago

Corbus Pharmaceuticals Announces Proposed Public Offering

WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering

PR Newswire

6 months ago

WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering

Rocky Mountain Chocolate Appoints Industry Veteran and Board Director Starlette B. Johnson as Interim Chief Executive Officer

GlobeNewswire

6 months ago

Rocky Mountain Chocolate Appoints Industry Veteran and Board Director Starlette B. Johnson as Interim Chief Executive Officer

OneMedNet Announces Participation as an Exhibitor at the 15ᵗʰ Annual SCOPE Summit

GlobeNewswire

6 months ago

OneMedNet Announces Participation as an Exhibitor at the 15ᵗʰ Annual SCOPE Summit

Is Vuzix (NASDAQ:VUZI) In A Good Position To Invest In Growth?

Simply Wall St.

6 months ago

Is Vuzix (NASDAQ:VUZI) In A Good Position To Invest In Growth?

2024 Promises An EV Evolution With New Clean Energy Solutions

Benzinga

6 months ago

2024 Promises An EV Evolution With New Clean Energy Solutions

SPI Energy Updates Fiscal 2023 Guidance

ACCESSWIRE

6 months ago

SPI Energy Updates Fiscal 2023 Guidance

Signing Day Sports Promotes Holistic Student-Athlete Wellbeing in the Sports Industry

GlobeNewswire

6 months ago

Signing Day Sports Promotes Holistic Student-Athlete Wellbeing in the Sports Industry

Solar360, Repsol and Telefónica Joint Venture, Partners with Turbo Energy to Revolutionize Solar Self-Consumption Through Artificial Intelligence

GlobeNewswire

6 months ago

Solar360, Repsol and Telefónica Joint Venture, Partners with Turbo Energy to Revolutionize Solar Self-Consumption Through Artificial Intelligence

SemiLEDs Reports First Quarter Fiscal Year 2024 Financial Results

Business Wire

6 months ago

SemiLEDs Reports First Quarter Fiscal Year 2024 Financial Results

Sidus Space Regains Compliance with Nasdaq Minimum Bid Requirements

Business Wire

7 months ago

Sidus Space Regains Compliance with Nasdaq Minimum Bid Requirements

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

GlobeNewswire

7 months ago

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

WISeKey and SEALSQ Launch at CES 2024 in Las Vegas a New Service to Elevate Cryptocurrency Security with Advanced Digital Identification and Robust Multi-Factor Authentication

GlobeNewswire

7 months ago

WISeKey and SEALSQ Launch at CES 2024 in Las Vegas a New Service to Elevate Cryptocurrency Security with Advanced Digital Identification and Robust Multi-Factor Authentication

MIND Technology Announces Deferral of Preferred Stock Dividend

PR Newswire

7 months ago

MIND Technology Announces Deferral of Preferred Stock Dividend

Super League to Host Virtual Non-Deal Roadshow Webinar on Wednesday, January 17, 2024, at 11:00 a.m. Eastern Time

GlobeNewswire

7 months ago

Super League to Host Virtual Non-Deal Roadshow Webinar on Wednesday, January 17, 2024, at 11:00 a.m. Eastern Time

Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024

PR Newswire

7 months ago

Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024

Wearable Devices Releases Mudra Developer Kit for Its Gesture Control Technology

GlobeNewswire

7 months ago

Wearable Devices Releases Mudra Developer Kit for Its Gesture Control Technology

Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator

GlobeNewswire

7 months ago

Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator

Leju Announces Receipt of NYSE Non-Compliance Letter

PR Newswire

7 months ago

Leju Announces Receipt of NYSE Non-Compliance Letter

Eco Wave Power Submits an Official Request to the SFSA to Receive an Authorization for the Repurchase of American Depositary Shares Representing Up to 10% of the Company's Shares

PR Newswire

7 months ago

Eco Wave Power Submits an Official Request to the SFSA to Receive an Authorization for the Repurchase of American Depositary Shares Representing Up to 10% of the Company's Shares

DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI

GlobeNewswire

7 months ago

DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI

Scilex Holding Company Announces Results from Market Research with Rheumatologists Reveal a High Degree of Interest in Gloperba® as a Liquid Colchicine Formulation Designed for Precision Dosing

GlobeNewswire

7 months ago

Scilex Holding Company Announces Results from Market Research with Rheumatologists Reveal a High Degree of Interest in Gloperba® as a Liquid Colchicine Formulation Designed for Precision Dosing

NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split

PR Newswire

7 months ago

NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split

Life Science Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire

7 months ago

Life Science Investor Forum: Presentations Now Available for Online Viewing

Registration Is Now Open For Tribe Public's Webinar Event "Diabetes Care For The Rest Of Us." Featuring Modular Medical CEO On Friday, December 15, 2023

ACCESSWIRE

8 months ago

Registration Is Now Open For Tribe Public's Webinar Event "Diabetes Care For The Rest Of Us." Featuring Modular Medical CEO On Friday, December 15, 2023

Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York

ACCESSWIRE

8 months ago

Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York

eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in ER+ Metastatic Breast Cancer Patients

GlobeNewswire

8 months ago

eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in ER+ Metastatic Breast Cancer Patients

Allarity’s Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP® Companion Diagnostic

GlobeNewswire

8 months ago

Allarity’s Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP® Companion Diagnostic

Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

GlobeNewswire

8 months ago

Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

Fusion Fuel Green Hosts Third Quarter 2023 Investor Update

GlobeNewswire

8 months ago

Fusion Fuel Green Hosts Third Quarter 2023 Investor Update

Zapata AI Welcomes Jon Zorio as Chief Revenue Officer

Business Wire

8 months ago

Zapata AI Welcomes Jon Zorio as Chief Revenue Officer

Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November

GlobeNewswire

8 months ago

Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November

BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS

PR Newswire

8 months ago

BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS

Kazia Therapeutics Limited's (NASDAQ:KZIA) large institutional owners must be happy as stock continues to impress, up 28% over the past week

Simply Wall St.

8 months ago

Kazia Therapeutics Limited's (NASDAQ:KZIA) large institutional owners must be happy as stock continues to impress, up 28% over the past week

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of October 2023

GlobeNewswire

8 months ago

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of October 2023

Rocky Mountain Chocolate Engages Award Winning Retail and Hospitality Store Design Firm to Lead the Refresh of Its Company and Franchised-Owned Stores

GlobeNewswire

8 months ago

Rocky Mountain Chocolate Engages Award Winning Retail and Hospitality Store Design Firm to Lead the Refresh of Its Company and Franchised-Owned Stores

Aware and Serban Group Team Up To Create Biometric Authentication Powerhouse Serving Latin American and European Markets

GlobeNewswire

8 months ago

Aware and Serban Group Team Up To Create Biometric Authentication Powerhouse Serving Latin American and European Markets

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Moving iMage Technologies Announces First Quarter Fiscal 2024 Results

Business Wire

8 months ago

Moving iMage Technologies Announces First Quarter Fiscal 2024 Results

Associated Press Finance

9 months ago

Golden Minerals: Q3 Earnings Snapshot

Golden Minerals Reports Third Quarter 2023 Financial Results

Business Wire

9 months ago

Golden Minerals Reports Third Quarter 2023 Financial Results

OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients

ACCESSWIRE

9 months ago

OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients

Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results

GlobeNewswire

9 months ago

Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results

CHARLES & COLVARD REPORTS FIRST QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

PR Newswire

9 months ago

CHARLES & COLVARD REPORTS FIRST QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

Lisata Therapeutics Announces Participation in Upcoming Conferences in November

GlobeNewswire

9 months ago

Lisata Therapeutics Announces Participation in Upcoming Conferences in November

FKM Sintertechnik, One of Germany's Largest Service Providers for 3D Printed Parts, Invests in voxeljet's Large-format VX1000 HSS Polymer Printer

Business Wire

9 months ago

FKM Sintertechnik, One of Germany's Largest Service Providers for 3D Printed Parts, Invests in voxeljet's Large-format VX1000 HSS Polymer Printer

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

PR Newswire

9 months ago

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

BEST Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

PR Newswire

9 months ago

BEST Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

Stonegate Capital Partners Updates Coverage on Independence Contract Drilling, Inc (ICD) Q3 2023

Newsfile

9 months ago

Stonegate Capital Partners Updates Coverage on Independence Contract Drilling, Inc (ICD) Q3 2023

Eterna Therapeutics Appoints Dr. James Bristol to Board of Directors

Exec Edge

9 months ago

Eterna Therapeutics Appoints Dr. James Bristol to Board of Directors

Coeptis Therapeutics Announces Research Demonstrating the Potential of SNAP-CAR T-cells to Reduce Tumor Burden and Growth in HER2 and CD20 Expressing Cancers Will be Presented at SITC 2023

PR Newswire

9 months ago

Coeptis Therapeutics Announces Research Demonstrating the Potential of SNAP-CAR T-cells to Reduce Tumor Burden and Growth in HER2 and CD20 Expressing Cancers Will be Presented at SITC 2023

Share on Social Networks: